CA2386534A1 - Crystal form ii of clarithromycin and uses thereof - Google Patents

Crystal form ii of clarithromycin and uses thereof Download PDF

Info

Publication number
CA2386534A1
CA2386534A1 CA002386534A CA2386534A CA2386534A1 CA 2386534 A1 CA2386534 A1 CA 2386534A1 CA 002386534 A CA002386534 A CA 002386534A CA 2386534 A CA2386534 A CA 2386534A CA 2386534 A1 CA2386534 A1 CA 2386534A1
Authority
CA
Canada
Prior art keywords
crystal form
clarithromycin
methylerythromycin
antiobiotic
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002386534A
Other languages
French (fr)
Other versions
CA2386534C (en
Inventor
Jih-Hua Liu
David A. Riley
Stephen G. Spanton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BGP Products Operations GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4163180&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2386534(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Priority claimed from CA002258606A external-priority patent/CA2258606C/en
Publication of CA2386534A1 publication Critical patent/CA2386534A1/en
Application granted granted Critical
Publication of CA2386534C publication Critical patent/CA2386534C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Abstract

The present invention concerns the novel antiobiotic 6-O-methylerythromycin A crystal Form I, a process for its preparation, pharmaceutical compositions comprising this compound and a method of use as a therapeutic agent.
CA002386534A 1997-07-25 1997-07-25 Crystal form ii of clarithromycin and uses thereof Expired - Lifetime CA2386534C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002258606A CA2258606C (en) 1996-07-29 1997-07-25 Crystal form ii of clarithromycin

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002258606A Division CA2258606C (en) 1996-07-29 1997-07-25 Crystal form ii of clarithromycin

Publications (2)

Publication Number Publication Date
CA2386534A1 true CA2386534A1 (en) 1998-02-05
CA2386534C CA2386534C (en) 2003-05-27

Family

ID=4163180

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002386534A Expired - Lifetime CA2386534C (en) 1997-07-25 1997-07-25 Crystal form ii of clarithromycin and uses thereof

Country Status (1)

Country Link
CA (1) CA2386534C (en)

Also Published As

Publication number Publication date
CA2386534C (en) 2003-05-27

Similar Documents

Publication Publication Date Title
CA2258606A1 (en) Crystal form ii of clarithromycin
CA2387356A1 (en) Crystal form 0 and form i of clarithromycin and uses thereof
ZA964624B (en) Process for the preparation of microcapsule compositions.
AU2053597A (en) Pharmaceutical compositions for the treatment of glaucoma
CA2278201A1 (en) Novel modifications to 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonyl-aminobenzene, and processes for their preparation
AU3080895A (en) Novel piperazides derived from arylpiperazine, processes for their preparation, their use as medicaments and pharmaceutical compositions comprising them
HUP9603495A3 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, pharmaceutical compositions containing the same and process for their preparation
EP0811595A4 (en) Hydrochalcone derivatives, comestic compositions containing the same, and processes for the preparation of both
HRP960558B1 (en) New crystalline modifications of cdch, processes for the preparation thereof and pharmaceutical compositions containing them
AU6362796A (en) Substituted 4-phenylaminothiazoles, their process for preparation and the pharmaceutical compositions containing them
CA2163837A1 (en) Crystalline Paclitaxel Hydrates
IL140897A0 (en) Benzocycloheptene derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
WO2001029055A3 (en) Novel oligosaccharides, preparation method and pharmaceutical compositions containing same
WO1997004788A3 (en) Use of calendula glycosides for the treatment of psoriasis
AU2841199A (en) Novel bis-benzamide derivatives, method for making same pharmaceutical compositions containing them and use thereof as medicine
HUP0001093A3 (en) Oxazolidines as 5-ht2a-antagonists, pharmaceutical compositions containing the same and process for their preparation
HUP9601680A3 (en) Benzisothiazolyl-substituted aminomethyl-chromanes, pharmaceutical compositions containing the same, process for their preparation and use of the compounds
CA2263846A1 (en) Novel pyranoside derivatives
HUP0102609A3 (en) N-phenyl-n'-phenylpropylpiperazine derivatives and process for the preparation thereof, and pharmaceutical compositions containing them
EP1059304A4 (en) Novel polysaccharide derivatives, process for the production thereof and medicinal compositions containing the same as the active ingredient
AU5525199A (en) N-hydroxyacylamino compounds, process for their preparation and pharmaceutical compositions containing them
CA2386534A1 (en) Crystal form ii of clarithromycin and uses thereof
AU3034595A (en) New tetrahydropyran compounds, process for the preparation thereof, and pharmaceutical compositions containing them
AU5494298A (en) Pharmaceutical compositions for the treatment of the eye
CA2386527A1 (en) Crystal form i of clarithromycin

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20170725

MKEX Expiry

Effective date: 20170725